Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
No biomarker
Cancer:
Testicular Seminoma
Regimen:
(carboplatin + etoposide IV + ifosfamide + paclitaxel)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
ESMO.org
Excerpt:
Chemotherapy regimens in metastatic seminoma and non-seminoma: TI-CE…paclitaxel + ifosfamide-carboplatin + etoposide…two cycles TI before stem cell harvesting, therafter three cycles CE as high-dose treatment.
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login